Kevin Appelbaum | Co-Founder and Chief Executive Officer |
Mark Berman | Chief Medical Officer |
Mark Heinen | Chief Financial Officer |
Thomas Flaten | Lake Street Capital |
Charles Rhyee | Cowen |
Keay Nakae | Chardan |
Rahul Rakhit | LifeSci Capital |
Good morning, and welcome to the Better Therapeutics First Quarter 2022 Financial Results and Business Update Conference Call. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference may be recorded. [Operator Instructions] I would now like to hand the call over to Kevin Appelbaum, Co-Founder and Chief Executive Officer. Please begin.